Preprint / Version 1

COVID-19 in Rio de Janeiro municipality: spatial distribution of the first deaths and cases confirmed

##article.authors##

DOI:

https://doi.org/10.1590/SciELOPreprints.130

Keywords:

SARS-CoV-2, COVID-19, Spatial Analysis, Epidemiology, Public Health, Brazil

Abstract

Objective: To analyze and describe the spatial distribution of the first confirmed cases and deaths of COVID-19 in Rio de Janeiro and its association with the Social Development Index (SDI). Methods: Data from confirmed cases and deaths of SARSCoV-2 between March 6 and April 10, 2020 were used. Incidence rates (IR), mortality (MR), lethality and excess risk were calculated. Results: The COVID- IR is 26.8, the MR 1.36 (both per 100 thousand inhabitants) and the lethality is 5%. The excess risk assessed that eight neighborhoods have an IR of 4-12 times greater than the municipality. Moran's I and LISA demonstrate global and local spatial autocorrelation. The regression demonstrated statistical significance between the SDI and the IR and MR. Conclusion: The elaboration of emergency plans against COVID-19 must consider the socioeconomic-cultural characteristics of the municipality.

Downloads

Download data is not yet available.

Author Biographies

João Roberto Cavalcante, Universidade do Estado do Rio de Janeiro

Doctorate in Public Health (IMS/UERJ), Master in Public Health (IMS/UERJ), Specialist in Law and Health (ENSP/Fiocruz), Specialist in Family Health (FS/UnB) and Bachelor of Public Health (IESC/UFRJ). He is currently a collaborating researcher at the Brazilian Center for Global Health and the Sérgio Veira de Mello Chair (UERJ). He has worked as a consultant for the Pan American Health Organization/ World Health Organization (PAHO/WHO), the Health Surveillance Strategic Information Center (CIEVS) of the Secretariat of Health Surveillance of the Ministry of Health (SVS/MS) and researcher of the projects: Human Resources Training Program in Environmental Health Surveillance (IESC/UFRJ), Plan of Epidemiological Monitoring of the Area of Influence of COMPERJ (Labmep/Fiocruz) and Longitudinal Study of Adult Health (ELSA/Fiocruz). Has professional experience with Global Health, Epidemiology, Health Surveillance, International Health Regulations, Digital Detection of Diseases, Participatory Surveillance and Refugee Health.

Ariane de Jesus Lopes de Abreu, International Vaccine Institute, Seoul, Republic of Korea

Possui graduação em Saúde Coletiva pela Universidade Federal do Rio de Janeiro (2013), Especialização em Direitos humanos, gênero e sexualidade pela ENSP/FIOCRUZ (2015) e em Auditoria de sistemas de saúde pela Universidade Estácio de Sá (2015). Atualmente é pesquisadora no Instituto Internacional de Vacinas, atuando em estudos clínicos, epidemiológicos e farmacoeconômicos em vacinas e doenças infecciosas. Cursando mestrado em Avaliação de Tecnologias em Saúde pelo Instituto Nacional de Cardiologia. Tem experiência na área de Saúde Coletiva, com ênfase em doenças infecciosas e imunopreveníveis, atuando principalmente nos seguintes temas: epidemiologia, avaliação de tecnologias em saúde, planejamento e gestão em saúde e farmacoeconomia.

Posted

2020-04-22

Section

Health Sciences